Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 42.88% is 29% above its 5-year average of 33.14%, around the middle of its 5-year range (0.38%–73.04%).
As of the fiscal period ended Tuesday, June 30, 2026. 20.98% below its 12-month average of 54.27%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 42.88%.
DEBT TO ASSETS RATIO
42.88%
DEBT TO ASSETS RATIO AVG TTM
54.27%
DEBT TO ASSETS RATIO AVG 3Y
43.54%
DEBT TO ASSETS RATIO AVG 5Y
33.14%
DEBT TO ASSETS RATIO AVG 10Y
19.50%
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-20.98%
CURRENT VS 3Y AVG
-1.52%
CURRENT VS 5Y AVG
+29.41%
CURRENT VS 10Y AVG
+119.87%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 873 covered companies
CURRENT VS SECTOR MEDIAN
+47547.64%
vs the sector median at left
Vivani Medical, Inc.
Market Cap
$106.93M
Debt to Assets Ratio
42.88%
TTM Avg
54.27%
3Y Avg
43.54%
5Y Avg
33.14%
Market Cap
$106.96M
Debt to Assets Ratio
0.70%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$106.98M
Debt to Assets Ratio
0.07%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$107.09M
Debt to Assets Ratio
0.03%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$107.17M
Debt to Assets Ratio
0.65%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$109.14M
Debt to Assets Ratio
0.09%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$104.68M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$104.26M
Debt to Assets Ratio
0.34%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Vivani Medical, Inc. (VANI) | $106.93M | 42.88% | 54.27% | 43.54% | 33.14% |
| Outlook Therapeutics, Inc. (OTLK)vs › | $106.96M | 0.70% | N/A | N/A | N/A |
| Cumberland Pharmaceuticals Inc. (CPIX)vs › | $106.98M | 0.07% | N/A | N/A | N/A |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP)vs › | $107.09M | 0.03% | N/A | N/A | N/A |
| Apyx Medical Corporation (APYX)vs › | $107.17M | 0.65% | N/A | N/A | N/A |
| Immunic, Inc. (IMUX)vs › | $106.52M | 0.00% | N/A | N/A | N/A |
| Insight Molecular Diagnostics Inc. (IMDX)vs › | $109.14M | 0.09% | N/A | N/A | N/A |
| Polaryx Therapeutics, Inc. Common Stock (PLYX)vs › | $104.68M | 0.00% | N/A | N/A | N/A |
| Definitive Healthcare Corp. (DH)vs › | $104.26M | 0.34% | N/A | N/A | N/A |
| Aardvark Therapeutics, Inc. Common Stock (AARD)vs › | $110.30M | 0.01% | N/A | N/A | N/A |
Debt/Assets
42.9%
Debt/Equity
0.94
Current Ratio
3.25
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 42.88% |
| 2026-03-31 | 43.15% |
| 2025-12-31 | 47.86% |
| 2025-09-30 | 73.04% |
| 2025-06-30 | 64.40% |
| 2025-03-31 | 53.42% |
| 2024-12-31 | 46.47% |
| 2024-09-30 | 45.88% |
| 2024-06-30 | 41.55% |
| 2024-03-31 | 37.88% |
| 2023-12-31 | 45.19% |
| 2023-09-30 | 39.49% |
| 2023-06-30 | 35.21% |
| 2023-03-31 | 2.83% |
| 2022-12-31 | 1.87% |
| 2022-09-30 | 2.25% |
| 2022-06-30 | 22.30% |
| 2022-03-31 | 16.17% |
| 2021-12-31 | 33.23% |
| 2021-09-30 | 0.38% |
| 2021-06-30 | 0.43% |
| 2021-03-31 | 9.12% |
| 2020-12-31 | 49.33% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 2.72% |
| 2019-12-31 | 15.68% |
| 2019-09-30 | 11.11% |
| 2019-06-30 | 8.59% |
| 2019-03-31 | 7.25% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 263.36% |
| 2014-06-30 | 191.44% |
| 2014-03-31 | 218.87% |
| 2013-12-31 | 151.59% |
